Despite efforts by governments in Latin America, illicit drugs continue to provide one of the largest incomes for criminal organizations, enabling them to penetrate and corrupt political and social institutions.
The UN General Assembly Special Session (UNGASS) on drugs is fast approaching 2016 and is an important opportunity to conduct a thorough and objective assessment of the international drug control system. This session will discuss remaining challenges, as well as opportunities for the way forward – in particular towards rebalancing current drug policies towards the core UN values of public health, human rights and development
In April 2012, most of the hemisphere’s presidents gathered at the Summit of the Americas in Cartagena, Colombia and held a closed-door meeting where drug policy was the only topic discussed. Following that meeting, Colombian President Juan Manuel Santos announced that the Organisation of American States (OAS) was being tasked to analyse the results of hemispheric drug policies and to “explore new approaches to strengthen this struggle and become more effective”. Thus began a one year process led by OAS Secretary General José Miguel Insulza, with the support of OAS staff from the Secretariat for Multidimensional Security and the Inter-American Drug Abuse Control Commission (CICAD), as well as a range of independent experts.
At the root of the drug policy debate in Latin America is growing recognition that present policies have failed to achieve the desired objectives, the extremely high costs of implementing those policies paid by Latin American countries, and the need to place higher priority on reducing unacceptably high levels of violence. Of particular concern is the spread of organized crime and the resulting violence, corruption and erosion of democratic institutions.
In March 2014, country delegations will gather at the United Nations Commission on Narcotic Drugs (CND) to review progress and challenges in international drug control since the agreement of a Political Declaration on drugs in 2009. Given that the Political Declaration aims to “eliminate or reduce significantly” the use, supply and demand of controlled drugs by 2019, this meeting represents an important opportunity for honest evaluation and an acknowledgement that these targets are not being achieved. With a United Nations General Assembly Special Session (UNGASS) on drugs just two years away, this is an important time for international drug control policy.
The upcoming United Nations General Assembly Special Session on Drugs (UNGASS) in 2016 is an unprecedented opportunity to review and re-direct national drug control policies and the future of the global drug control regime. As diplomats sit down to rethink international and domestic drug policy, they would do well to recall the mandate of the United Nations, not least to ensure security, human rights and development.
This report argues that ‘drugs’ are a development issue and must be recognised as such by development agencies. The cultivation of opium poppy, coca leaf and cannabis for anything other than medical and scientific purposes is prohibited under the UN 1961 Single Convention on Narcotic Drugs, as amended by the 1972 Protocol. However conditions of marginalisation and exclusion have sustained the cultivation of these low capital input/high yield drug crops. Poverty, insecurity and inequality also exacerbate the vulnerability of ‘bridge’ states to trafficking activities. These factors are development concerns requiring economic and political solutions.
As the world prepares for the 2016 Special Session of the United Nations General Assembly on the World Drug Problem (UNGASS 2016), an increasing number of countries around the world now find the regime’s emphasis on punitive approaches to illicit drugs to be problematic and are asking for reform. In this moment of global disagreement, the Brookings project on Improving Global Drug Policy provides a unique comparative evaluation of the effectiveness and costs of international counternarcotics policies and best approaches to reform.
The international drug control regime is facing the most profound challenge of its existence. Member states have for some time been experimenting with new responses to the ‘world drug problem’; however, the advent of legally regulated cannabis markets has resulted in a ratcheting up of these challenges to expose the system to new levels of strain. With the 2016 UN General Assembly Special Session (UNGASS) on the world drug problem fast approaching, how will the international community make use of the opportunity it provides for a free and open debate?
Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.
On 19th to 21st April 2016, there will be a United Nations General Assembly Special Session (UNGASS) held in New York, dedicated to the issue of drug policy. The General Assembly is the highest policy making and representative organ of the United Nations (UN), and its infrequent Special Sessions focus on pertinent topics at the request of member states. The UNGASS on drugs has the potential to be a ground-breaking, open debate about the international drug control system – but there is much work to be done to ensure that it fulfils that potential.
At the annual UN General Assembly meeting held in New York, presidents from around the world have the chance to state their views on the key international issues of the day. Not surprisingly, the crisis in Syria, Iran’s pursuit of nuclear weapons and the Millennium Development Goals took center stage this year. Yet a careful viewing of the speeches of the Latin American presidents illustrates the growing voice of Latin American leaders calling for meaningful reform of drug control policies.
Kofi Annan Secretary General of the United Nations, Fernando Henrique Cardoso
05 November 2013
Each year, hundreds of thousands of people around the world die from preventable drug-related disease and violence. Millions of users are arrested and thrown in jail. Globally, communities are blighted by drug-related crime. Citizens see huge amounts of their taxes spent on harsh policies that are not working. But despite this clear evidence of failure, there is a damaging reluctance worldwide to consider a fresh approach. The Global Commission on Drug Policy is determined to help break this century-old taboo. See IDPC Press Release.
Country delegations to the UN Commission on Narcotic Drugs (CND) don’t usually vote on things… The protocol is that member states reach consensus on language and policy (often meaning that the final language reflects the lowest common denominator). Usually this diplomatic process works and delegates compromise. However, at the most recent inter-sessional meeting of the CND on 5th November, some delegates drew “red lines” and staked out non-negotiable positions on key issues.
Major divisions over the global "war on drugs" have been revealed in a leaked draft of a UN document setting out the organisation's long-term strategy. The draft, written in September shows there are serious divisions over the longstanding US-led policy promoting prohibition as an solution to the problem. Instead, a number of countries are pushing for the "war on drugs" to be seen in a different light, placing greater emphasis on treating drug consumption as a public health problem, rather than a criminal justice matter. (See also: Drug control policies are changing: Why? And why has it taken so long?)